SCHEMBL3779326

SCHEMBL3779326

CCCCCc1ccc(OCCCCCCOc2ccc(B(O)O)cc2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LPL P06858 7/20 0.76
LIPG Q9Y5X9 7/20 0.76
TRPV1 Q8NER1 1/20 0.76
MGLL Q99685 1/20 0.76
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
MEN1 O00255 1/20 0.61
USP2 O75604 1/20 0.61
ALDH1A1 P00352 1/20 0.61
LMNA P02545 1/20 0.61
CYP3A4 P08684 1/20 0.61
MAPK1 P28482 1/20 0.61
CASP1 P29466 1/20 0.61
KMT2A Q03164 1/20 0.61
SMN1; SMN2 Q16637 1/20 0.61
SLCO1B3 Q9NPD5 1/20 0.61
SLCO1B1 Q9Y6L6 1/20 0.61
NR5A1 Q13285 1/20 0.54
PLA2G4A P47712 1/20 0.49
S1PR4 O95977 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29669939 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL7610345 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL8705732 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL2401172 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL7472946 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL2354047 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL2671160 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL8216263 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL8208913 0.91 NR5A1 (0.65) LPLLIPGTRPV1MGLLCA1
SCHEMBL1006706 0.89 NR5A1 (0.61) LPLLIPGTRPV1MGLLCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9102652-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2015-08-11 US disclosed
EP-2076504-B1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INC (US) 2014-05-14 EP disclosed
US-8697890-B2 Dichroic-photochromic 2H-naphtho[1,2-b]pyran compounds and devices ALPHAMICRON INCORPORATED (US) 2014-04-15 US disclosed
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON INCORPORATED 2010-12-23 US disclosed
EP-2076504-A2 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES AlphaMicron, Inc. (US) 2009-07-08 EP disclosed
WO-2008051420-A2 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES ALPHAMICRON, INC. (US) 2008-05-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100324296-A1 DICHROIC-PHOTOCHROMIC COMPOUNDS AND DEVICES NR0B2, NR0B1, NR2E3 LPL 4371/4885LIPG 4715/4885TRPV1 484/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.